Seoul, South Korea and BURLINGAME, Calif., March 22, 2022 /PRNewswire/ — Arum Therapeutics Inc. (Arum), a leading pharmaceutical company specializing in the discovery of novel molecules and combinations of molecules to target novel oncology, today announced that it has implemented Fixed-term safea research data management platform developed by Collaborative Drug Discovery, Inc. (CDD), in its Gangseo-gu laboratories, Seoul.
Arum’s research focuses on discovering new chemical entities that will act as effective therapies for drug-resistant cancers. The company exploits the concept of synthetic lethality targeting the DNA damage response (DDR) with the aim of blocking the primary repair and rescue mechanisms of the cancer cell, thus rendering it unable to survive. Additional pipelines in oncotargets complement the company’s strong pipeline in this area.
“At Arum, we are focused on treating cancers where conventional therapies are no longer effective. We have a unique approach that requires efficient and secure data management and we have found that CDD Vault meets these requirements. We can easily access and navigate data in an intuitive way that allows us to be more productive,” said Taegon BaikCEO of Arum Therapeutics, “We expect the platform to grow with us as we grow the business and move our pipeline downstream.”
Arum’s research data is stored, managed and analyzed in CDD Vault, a hosted computing platform designed to manage drug discovery data and facilitate secure collaborations. The versatility of CDD Vault allows Arum to organize chemical, biological, and even mixture entities, along with associated protocols and experiment results.
“We are excited to see Arum use the unique capabilities of CDD Vault to gain insights from multiple data types and collaborate across disciplines,” said Barry BuninCDD CEO, “It is a real pleasure to support the growth and expansion of Arum. Their innovative approach to targeting drug-resistant cancer brings hope to millions of patients around the world.”
About Arum Therapeutics Inc.
Therapeutic Arum (https://arumtherapeutics.com) is a leading pharmaceutical company with strength in medicinal chemistry based on synthetic small molecules. The company is developing new anticancer agents to overcome current drug resistance using a platform for synthetic lethality (SL) targeting associated with DNA damage response (DDR) mechanisms. The company is based in Seoul, South Korea.
About Collaborative Drug Discovery, Inc.
CDD (www.collaborativedrug.com) flagship product, “CDD Vault”, is used to manage chemical registration, structure-activity relationships (SAR), and scale collaborations securely. CDD Vault® is a hosted database solution for securely managing and sharing biological and chemical data. It allows you to intuitively organize chemical structures and biological study data and collaborate with internal or external partners through an easy-to-use web interface. Modules available in CDD Vault include Activity and Record, View, Inventory, and ELN.
dr. Mariana Vaschetto
SOURCE Collaborative Drug Discovery